Literature DB >> 15243337

[5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?].

Pierre Desreumaux1, Olivier Romano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15243337     DOI： 10.1016/s0399-8320(04)94978-0

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  4 in total

Review 1.  Current and emerging therapeutic targets for IBD.

Authors:  Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-01       Impact factor: 46.802

Review 2.  Immunological pathogenesis of inflammatory bowel disease.

Authors:  Seung Hoon Lee; Jeong Eun Kwon; Mi-La Cho
Journal:  Intest Res       Date:  2018-01-18

Review 3.  Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD.

Authors:  Victoria Klepsch; Alexander R Moschen; Herbert Tilg; Gottfried Baier; Natascha Hermann-Kleiter
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

4.  Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.

Authors:  M A Kamm; G R Lichtenstein; W J Sandborn; S Schreiber; K Lees; K Barrett; R Joseph
Journal:  Gut       Date:  2008-02-13       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.